Tarikh laporan akan datang
—
Tempoh masa laporan
—
Anggaran EPS
—
Anggaran hasil
—
12.04 MXN
16.51 B MXN
488.67 B MXN
3.17 B
Mengenai TAKEDA PHARMACEUTICAL CO LTD
Sektor
Ketua Pegawai Eksekutif
Christophe Weber
Ibu pejabat
Osaka
Laman Web
Ditubuhkan
1781
FIGI
BBG00N0NV1H3
Pandangan agregat penarafan profesional.
Memaparkan pergerakan harga simbol sepanjang tahun-tahun sebelumnya untuk mengenalpasti trend berulang.
TKPH5010047
Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050Hasil kepada kematangan
6.48%
Tarikh Matang
9 Jul 2050
TKPH5010048
Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060Hasil kepada kematangan
6.45%
Tarikh Matang
9 Jul 2060
TKPH5010046
Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040Hasil kepada kematangan
6.23%
Tarikh Matang
9 Jul 2040
TKPH5841810
Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064Hasil kepada kematangan
5.73%
Tarikh Matang
5 Jul 2064
B
TKPH4369980
Baxalta Incorporated 5.25% 23-JUN-2045Hasil kepada kematangan
5.69%
Tarikh Matang
23 Jun 2045
TKPH5841809
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054Hasil kepada kematangan
5.59%
Tarikh Matang
5 Jul 2054
TKPH5841808
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044Hasil kepada kematangan
5.48%
Tarikh Matang
5 Jul 2044
TKPH5010045
Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030Hasil kepada kematangan
5.22%
Tarikh Matang
31 Mac 2030
TKPH5841807
Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034Hasil kepada kematangan
5.19%
Tarikh Matang
5 Jul 2034
B
TKPH4370840
Baxalta Incorporated 4.0% 23-JUN-2025Hasil kepada kematangan
4.94%
Tarikh Matang
23 Jun 2025
TKPH4770188
Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028Hasil kepada kematangan
4.73%
Tarikh Matang
26 Nov 2028
Terokai lebih bon